drugset / Trial / NCT04739592

A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis

NCT04739592

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effect of alendronate sodium vitamin D3 tablets compared with placebo on the improvement of joint structure and joint pain in participants with knee osteoarthritis. The treatment period of this study is one year and followed-up period is 2 years. The results of knee joint MRI will be evaluated by using the WORMS score.

Timeline

Start
2021-07-07
Primary completion
2023-07
Completion
2024-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule
Subject Cholecalciferol Other / unclassified

Indications